The 20 references in paper Yu. Samuleeva V., V. Zadionchenko S., V. Li V., T. Adasheva V., E. Samorukova I., A. Pikhlak E., V. Logachev A., L. Sokolova B., Ю. Самулеева В., В. Задионченко С., В. Ли В., Т. Адашева В., Е. Саморукова И., А. Пихлак Э., В. Логачев А., Л. Соколова Б. (2015) “Ожирение и метаболические нарушения у больных хронической обструктивной болезнью легких: возможности фенотипирования // Obesity and metabolic disorders in COPD patients: opportunities for phenotyping” / spz:neicon:pulmonology:y:2014:i:5:p:32-38

1
Han M.K., Agusti A., Calverley P.M. et al. COPD phenotypes: The future of COPD.Am. J .Respir. Crit. Care Med.
(check this in PDF content)
2
10; 182: 598–604. 2. Авдеев С.Н. Фенотипы хронической обструктивной болезни легких: особенности терапии. Consilium medicum. 2010; 1: 23–28.
(check this in PDF content)
3
Eisner M.D., Blanc P.D., Sidney S. et al. Body composition and functional limitation in COPD.Respir. Res. 2007; 8: 7.
(check this in PDF content)
4
Vozoris N.T., O'Donnell D.E. Prevalence, risk factors, activity limitation and health care utilization of an obese population-based sample with chronic obstructive pulmonary disease.Can. Respir. J. 2012; 19: e18–e24.
(check this in PDF content)
5
Lam K-B.H., Jordan R.E., Jiang C.Q. et al. Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study. Eur. Respir. J. 2010; 35: 317–323.
(check this in PDF content)
6
Оганов Р.Г. (ред.). Национальные рекомендации по диагностике и лечению метаболического синдрома. Национальные клинические рекомендации. 3-е изд. М.: "Солицея–Полигра"; 2010. 278–316.
(check this in PDF content)
7
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Revised 2007.
(check this in PDF content)
8
Яшина Л.А. Избыточная масса тела, ожирение и патология легких: взгляд пульмонолога. Здоров'я Украiни. 2011; 2 (14): 14–15.
(check this in PDF content)
9
Celli B.R., Cote C.G., Marin J.M. et al. The body mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 1005–1012.
(check this in PDF content)
10
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Revised 2013.www.goldcopd.org
(check this in PDF content)
11
Sava F. Maltais F., Poirier P. The Impact of Obesity and Metabolic Syndrome in COPD. Bronchitis. [Электронный ресурс]; 2011. Режим доступа: http://www.intechopen. com/books/bronchitis/the-impact-of-obesity-and-metabolicsyndrome-in-copd
(check this in PDF content)
12
Eagan T.M.L., Aukrust P., Ueland T. et al. Body composition and plasma levels of inflammatory biomarkers in COPD. Eur. Respir. J. 2010; 36: 1027–1033.
(check this in PDF content)
13
Leone N., Courbon D., Thomas F. Lung function impairment and metabolic syndrome. The critical role of abdominal obesity. Am. J. Respir. Crit. Care Med. 2009; 179: 509–516.
(check this in PDF content)
14
Ora J., Laveneziana P., Ofir D. et al. Combined effects of obesity and COPD on dyspnea and exercise tolerance. Am. J. Respir. Crit. Care Med. 2009; 180: 964–971.
(check this in PDF content)
15
Tkacova R. Systemic Inflammation in chronic obstructive pulmonary disease: May adipose tissue play a role? Review of the literature and future perspectives. Hindawi Publishing Corporation. Mediators of Inflammation. 2010; 1–11.
(check this in PDF content)
16
Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metabol. 2004; 89 (6): 2548–2556.
(check this in PDF content)
17
Fontana L., Eagon J.C., Trujillo M.E. et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.Diabetes. 2007; 56 (4): 1010–1013.
(check this in PDF content)
18
Антипина А.Н. Особенности клинико-лабораторных проявлений хронической обструктивной болезни легких у больных с ожирением различной степени: Автореф. дис. ... канд. мед. наук. Тюмень; 2011.
(check this in PDF content)
19
Данилова Л.И. Феномен инсулинорезистентности в клинической практике: механизмы формирования и возможности коррекции.Лечебное дело. 2009; 2 (6): 29–40.
(check this in PDF content)
20
Regazzetti С., Peraldi P., Grémeaux T. et al. Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes. 2009; 58 (1): 95–103. Поступила 16.01.14 УДК 616.24-002-036.12-07:616-008.915-074
(check this in PDF content)